GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [PSA] glycaemic control is not what most of this community thinks it is — 34 comments in the full submission. View in context.
1.5k
c/t2dglp1·submitted 11 months ago by u/aleksi_eriksen

[PSA] glycaemic control is not what most of this community thinks it is

CGMbranch of 7 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on metformin in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with…

Read the full submission and all 34 comments →

This branch

7 comments, started 11 months ago
u/gustav_lindholm14 points·11 months ago

Australia here. Waited 9 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
u/wanjiru_osei10 points·11 months ago

The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.

replysharereportpermalink
u/camila_vasquez5 points·11 months ago

type 2 is the indication, weight loss is the side effect

replysharereportpermalink
u/hugo_norgaard2 points·11 months ago

I am going to push back on this slightly.

replysharereportpermalink
u/tomas_lundgren17 points·11 months ago

Strongly agree. A1c matters as much as weight.

replysharereportpermalink
u/gradient_goblin8 points·11 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/emil_okwuosa4 points·11 months ago

hypoglycaemia risk when stacked with A1c

replysharereportpermalink

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/t2dglp1
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/a1c_arcu/fasting_insulin_fu/gentle_correction
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →